Clinical efficacy of Biejiaruangan compound tablets in treatment of primary biliary cirrhosis
ObjectiveTo evaluate the clinical efficacy of Biejiaruangan compound tablets in the treatment of primary biliary cirrhosis (PBC). MethodsIn a randomized, double-blind, placebo-controlled study, 56 patients with PBC were collected and equally divided into treatment group and control group. The treatm...
Main Author: | HUANG Lingying |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2015-02-01
|
Series: | Linchuang Gandanbing Zazhi |
Subjects: | |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=6266&ClassID=11415055 |
Similar Items
-
Effect of Compound Biejiaruangan Tablets combined with entecavir therapy on liver fibrosis process and immune response state in patients with chronic hepatitis b
by: Qin Yang, et al.
Published: (2018-05-01) -
Research advances in primary biliary cirrhosis
by: ZHU Jiangyi
Published: (2015-02-01) -
Epidemiology and natural history of primary biliary cirrhosis
by: WANG Lifeng
Published: (2015-02-01) -
Primary biliary cirrhosis
by: Mary Eugenia Rinella
Published: (2006-07-01) -
Clinical efficacy of traditional Chinese medicine/herbal decoction combined with ursodeoxycholic acid for primary biliary cirrhosis: a meta-analysis
by: DU Ying
Published: (2015-01-01)